دورية أكاديمية
Denervación renal en el tratamiento de la hipertensión arterial. Posicionamiento conjunto de la SEH-LELHA y la ACI-SEC
| العنوان: | Denervación renal en el tratamiento de la hipertensión arterial. Posicionamiento conjunto de la SEH-LELHA y la ACI-SEC |
|---|---|
| المؤلفون: | Rodríguez Leor, Oriol, Jaén Águila, Fernando, Segura, Julián, Núñez Gil, Iván J., García Touchard, Arturo, Rubio, Esther, Troya, Maribel, Diego Mediavilla, Juan, Cequier, Ángel, Moreno, Raúl, Martell Claros, Nieves, Beltrán, Paola, Molina, Eduardo, García Donaire, José Antonio |
| المصدر: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
| بيانات النشر: | Publicidad Permanyer, SLU |
| سنة النشر: | 2023 |
| المجموعة: | Dipòsit Digital de la Universitat de Barcelona |
| مصطلحات موضوعية: | Hipertensió, Factors de risc en les malalties, Malalties cardiovasculars, Nefrologia, Hypertension, Risk factors in diseases, Cardiovascular diseases, Nephrology |
| الوصف: | Hypertension is the most prevalent cardiovascular risk factor. Despite pharmacological treatment, a high percentage of patients do not achieve an adequate blood pressure control. Renal sympathetic denervation is a minimally invasive intervention for the management of hypertension involving the interruption of the renal artery sympathetic nervous system using a catheter-based approach. The early studies showed promising results, but the controversial results coming from the SYMPLICITY HTN-3 trial sent this technique into oblivion. Over the last 3 years, new clinical trials have appeared including new devices used in different populations, which definitively proves the effectiveness of renal sympathetic denervation. This joint position statement from the Spanish Society of Hypertension-Spanish League for Combating High Blood Pressure (SEH-LELHA), and the Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC) reviews the evidence available on the efficacy and safety profile of renal sympathetic denervation for the management of hypertension. Based on the results of clinical trials, recommendations have been established on what patients may be eligible for renal sympathetic denervation and under what circumstances. |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | 8 p.; application/pdf |
| اللغة: | English |
| تدمد: | 2604-7322 |
| العلاقة: | Reproducció del document publicat a: https://doi.org/10.24875/RECICE.M21000235Test; REC: interventional cardiology (English Edition), 2022, vol. 4, num 1, p. 39-46; https://doi.org/10.24875/RECICE.M21000235Test; http://hdl.handle.net/2445/193140Test |
| الإتاحة: | https://doi.org/10.24875/RECICE.M21000235Test http://hdl.handle.net/2445/193140Test |
| حقوق: | cc by-nc-nd (c) Sociedad Española de Cardiología, 2021 ; http://creativecommons.org/licenses/by-nc-nd/3.0/esTest/ ; info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.8458B66B |
| قاعدة البيانات: | BASE |
| تدمد: | 26047322 |
|---|